Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
NGS Oncology Melanoma Profile (Tissue Only) Diagnostic Laboratory Services, Inc. United States | 1 | 41 |
|
Diagnostic Laboratory Services, Inc. United States | 5 | 40 |
|
Hereditary Melanoma and/or Pancreatic Cancer, CDKN2A Gene GeneKor MSA Greece | 3 | 1 |
|
PathGroup United States | 73 | 505 |
|
Clinical Cancer Genomics Laboratory University of California, San Francisco United States | 2 | 2 |
|
GoPath Laboratories, LLC United States | 1 | 3 |
|
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF and MSI Mutation Analysis PathGroup United States | 15 | 1 |
|
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States | 23 | 3 |
|
BRAF, NRAS, KIT Mutation Analysis PathGroup United States | 16 | 3 |
|
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States | 25 | 3 |
|
PathGroup United States | 15 | 2 |
|
Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States | 4 | 1 |
|
IntelligeneCG LLC United States | 13 | 9 |
|
Invitae United States | 34 | 147 |
|
Invitae United States | 18 | 61 |
|
PrimBio Research Institute United States | 60 | 50 |
|
Melanoma, somatic mutation sequencing panel Genome Diagnostics Lab University Health Network Canada | 1 | 5 |
|
BRAF codon 600 targeted mutation testing Genome Diagnostics Lab University Health Network Canada | 4 | 1 |
|
Comprehensive Panel for Individualized Cancer Threatment GeneKor MSA Greece | 16 | 52 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.